Page 149 - 南京医科大学学报自然科学版

第42卷第6期 徐静纯，王 聪. H3K27me3在肿瘤中的研究进展［J］.
2022年6月 南京医科大学学报（自然科学版），2022，42（06）：897-902 ·901 ·

mediated down⁃regulation of E⁃cadherin［J］. J Cell Physi⁃ ［21］ FONTES⁃SOUSA M，LOBO J，LOBO S，et al. Digital im⁃
ol，2018，233（2）：1359-1369 aging ⁃ assisted quantification of H3K27me3 immunoex⁃
［8］ YI J Q，SHI X M，XUAN Z Y，et al. Histone demethylase pression in luminal A/B ⁃ like，HER2 ⁃ negative，invasive
UTX/KDM6A enhances tumor immune cell recruitment， breast cancer predicts patient survival and risk of recur⁃
promotes differentiation and suppresses medulloblastoma rence［J］. Mol Med，2020，26（1）：22
［J］. Cancer Lett，2021，499：188-200 ［22］ HEALEY M A，HU R，BECK A H，et al. Association of
［9］ SU I H，BASAVARAJ A，KRUTCHINSKY A N，et al. H3K9me3 and H3K27me3 repressive histone marks with
Ezh2 controls B cell development through histone H3 breast cancer subtypes in the nurses’health study［J］.
methylation and Igh rearrangement［J］. Nat Immunol， Breast Cancer Res Treat，2014，147（3）：639-651
2003，4（2）：124-131 ［23］ HSIEH I Y，HE J C，WANG L，et al. H3K27me3 loss
［10］ WEI Y K，XIA W Y，ZHANG Z H，et al. Loss of trimethy⁃ plays a vital role in CEMIP mediated carcinogenesis and
lation at lysine 27 of histone H3 is a predictor of poor out⁃ progression of breast cancer with poor prognosis［J］.
come in breast，ovarian，and pancreatic cancers［J］. Mol Biomed Pharmacother，2020，123：109728
Carcinog，2008，47（9）：701-706 ［24］ DU T H，WANG D，WAN X Y，et al. Regulatory effect of
［11］ BERNARDES N E，CHOOK Y M. Nuclear import of his⁃ microRNA⁃223⁃3p on breast cancer cell processes via the
tones［J］. Biochem Soc Trans，2020，48（6）：2753-2767 Hippo/Yap signaling pathway［J］. Oncol Lett，2021，22
［12］ ASATOOR A M. The occurrence of Epsilon⁃N⁃methylly⁃ （1）：516
sine in human urine［J］. Clin Chim Acta，1969，26（1）： ［25］ MA L，SHAN L. ACTL6A promotes the growth in non ⁃
147-154 small cell lung cancer by regulating Hippo/Yap pathway
［13］ KIM S，PAIK W K. Studies on the origin of Epsilon⁃N⁃ ［J］. Exp Lung Res，2021，47（5）：250-259
methyl⁃L⁃lysine in protein［J］. J Biol Chem，1965，240 ［26］ LIU X，LI C，ZHANG R D，et al. The EZH2⁃ H3K27me3⁃
（12）：4629⁃4634 DNMT1 complex orchestrates epigenetic silencing of the
［14］ ZHANG J，JING L，LI M H，et al. Regulation of histone ar⁃ wwc1 gene，a Hippo/YAP pathway upstream effector，in
ginine methylation/demethylation by methylase and de⁃ breast cancer epithelial cells［J］. Cell Signal，2018，51：
methylase（review）［J］. Mol Med Rep，2019，19（5）： 243-256
3963-3971 ［27］ SUNG H，FERLAY J，SIEGEL R L，et al. Global cancer sta⁃
［15］ WANG Z Z，CAI H R，ZHAO E H，et al. The diverse roles tistics 2020：GLOBOCAN estimates of incidence and mor⁃
of histone demethylase KDM4B in normal and cancer de⁃ tality worldwide for 36 cancers in 185 countries［J］. CA
velopment and progression［J］. Front Cell Dev Biol，2022， Cancer J Clin，2021，71（3）：209-249
9：790129 ［28］ HE W P，LI Q，ZHOU J，et al. Decreased expression of
［16］ VAN WIJNEN A J，BAGHERI L，BADRELDIN A A，et al. H3K27me3 in human ovarian carcinomas correlates with
Biological functions of chromobox（CBX）proteins in stem more aggressive tumor behavior and poor patient survival
cell self⁃renewal，lineage⁃commitment，cancer and deve⁃ ［J］. Neoplasma，2015，62（6）：932-937
lopment［J］. Bone，2021，143：115659 ［29］ LIU T，CAI J，CAI J，et al. EZH2⁃miRNA positive feed⁃
［17］ INOUE A，JIANG L，LU F L，et al. Maternal H3K27me3 back promotes tumor growth in ovarian cancer［J］. Front
controls DNA methylation ⁃ independent imprinting［J］. Oncol，2021，10：608393
Nature，2017，547（7664）：419-424 ［30］ CAI C Y，PENG X，ZHANG Y M. Downregulation of cell
［18］ LIU F，GU L，CAO Y，et al. Aberrant overexpression of division cycle ⁃ associated protein 7（CDCA7）suppresses
EZH2 and H3K27me3 serves as poor prognostic biomark⁃ cell proliferation，arrests cell cycle of ovarian cancer，and
er for esophageal squamous cell carcinoma patients［J］. restrains angiogenesis by modulating enhancer of zeste ho⁃
Biomarkers，2016，21（1）：80-90 molog 2（EZH2）expression［J］. Bioengineered，2021，12
［19］ LIN S F，ZHOU M H，LI Y P，et al. H3K27 trimethylation （1）：7007-7019
and H3K9 dimethylation as poor prognostic markers for ［31］ LIN L，WANG Z W，JIN H H，et al. miR⁃212/132 is epi⁃
patients with esophageal squamous cell carcinoma［J］. Int genetically downregulated by SOX4/EZH2 ⁃ H3K27me3
J Clin Exp Pathol，2019，12（7）：2657-2664 feedback loop in ovarian cancer cells［J/OL］. Tumour Bi⁃
［20］ CHRUN E S，MODOLO F，DANIEL F I. Histone modifica⁃ ol，2016，2016. doi：10.1007/S13277⁃016⁃5339⁃9
tions：a review about the presence of this epigenetic phe⁃ ［32］ SUN S，YANG Q，CAI E，et al. EZH2/H3K27Me3 and
nomenon in carcinogenesis［J］. Pathol Res Pract，2017， phosphorylated EZH2 predict chemotherapy response and
213（11）：1329-1339 prognosis in ovarian cancer［J］. PeerJ，2020，8：e9052